Great Information, Real Community, Better Living.
 Main Page
 Shoulder News
Feature Story
Shoulder Technology
Real Life Recoveries
 Education Center
 Shoulder  Hero™
Dr. Evan Flatow:
Innovating Shoulder Surgery
About Heroes
 Join the Discussion in  Our Forums
Shoulder1 Forums
Patient Stories
Shoulder Journals
Ask an Expert
Locate a Doctor
Reference Library
Video Library
 Bookmark Us
Search the Body1 Network
April 21, 2014  


After spending two years in financial business, Dr. Kenneth Alleyne decided to pursue his life-long interest in medicine on a professional level. He trained at the Wake Forest University School of Medicine and completed a research fellowship at Harvard-MIT Division of Health Sciences and Technology. His residency training was undertaken at the Howard University Hospital. Dr. Alleyne recently completed a Sports Medicine Fellowship at Yale's School of Medicine and is currently in private practice in Connecticut. Dr. Alleyne is also a founder of Morphogen Pharmaceuticals and an author of multiple published research papers, including a presentation on the longest follow-up on arthroscopic partial menisectomy in recreational athletes. Dr. Alleyne is a graduate of Williams College (MA).


Dr. David S. Bailie chairs the Department of Orthopedic Surgery at Scottsdale Healthcare Shea (Hospital) in Scottsdale, Arizona, and he sees patients from all walks of life at The Orthopedic Clinic Association (TOCA) in Scottsdale, Arizona. A graduate of the University of Michigan, the Indiana University School of Medicine and was a post-graduate fellowship in Sports Medicine and Arthroscopic Surgery at Baylor Sports Medicine Institute in Houston, Texas. , Dr. Bailie specializes in all sports medicine injuries and arthroscopic surgery, including shoulder reconstruction.


Joe’s work is at the intersection of government, business and technology. Joe is the Senior Vice President of Government Affairs for ML Strategies, a division of Mintz Levin Cohen, Ferris, Glovsky and Popeo. Prior to ML Strategies, he served seven years as the Executive Director of the Massachusetts Technology Park Corporation (MTPC). As Massachusetts Secretary of Economic Affairs under former Governor Michael Dukakis, Joe established the Massachusetts Technology Collaborative (MTC), which initiated and then spun out the Medical Device Industry Council (MassMEDIC). Prior to his tenure as Secretary of the Executive Office of Economic Affairs, he served as Partner and Chairman of the Government and Public Affairs Department for Mintz, Levin, Cohen, Ferris, Glovsky and Popeo, a Boston-based law firm. He was President of the New England Legal Foundation and Corporate Counsel for the City of Boston in the administration of Mayor Kevin H. White. He served for three years on the board of MassMEDIC and for four years as Senior Advisor to the Massachusetts Biotechnology Council and has worked with the Pharmaceutical Research and Manufacturers of America (PhRMA) on establishing a New England Institute for Health Care Research and Innovation. Joe is a graduate of Dartmouth College and Harvard Law School, and was a Fellow at Harvard’s JFK School of Government. He is admitted to the practice of law in Massachusetts and the District of Columbia and before the United States Supreme Court.


Dr. Forwand is Chief of Cardiology at Harvard’s Mt. Auburn Hospital, one of the nation’s top 100 cardiology centers. He is also Assistant Professor of Clinical Medicine at Harvard Medical School. He studied medicine and received degrees from Columbia University College of Physicians and Surgeons and Union College in Schenectady, New York. Dr. Forwand is an author of numerous technical papers and abstracts and is currently overseeing several clinical studies in arrhythmia management and cardiac pacing.


A native of the Buffalo, NY region, Dr. Joshua Siegel received his Bachelor’s Degree from Northwestern University, and his Medical Degree Summa Cum Laude from SUNY Buffalo. He then completed five years of orthopaedic residency training in Syracuse, NY before completing a fellowship in Orthopaedic Sports Medicine at the renowned American Sports Medicine Institute in Birmingham, Alabama, where he trained with Dr. Jim Andrews and Dr. Bill Clancy. Dr. Siegel has special training in throwing injuries to the shoulder and elbow and is involved in clinical research and product development. Dr. Siegel is Board Certified, a member of the American Orthopedic Society for Sports Medicine (AOSSM), and a member of the Sports Medicine Fellowship Society. His professional interests revolve around the surgical and medical treatment of all athletic injuries. Dr. Siegel currently practices at Access Sports Medicine and Orthopaedics in Exeter, New Hampshire.


Rebecca Lobo is one of the premiere athletes in women's sports and a forward for the WNBA's New York Liberty. Rebecca's accomplishments include captaining an undefeated University of Connecticut team that won the NCAA women's basketball championship and being named the 1995 National College Player of the Year. She also won a gold medal as part of the 1996 USA National Women's Basketball team and has co-written the book "Home Team" about her mother's battle with breast cancer. Rebecca also serves as a national spokesperson for Body1. Due to her recurring problems with a torn anterior cruciate ligament (ACL), Rebecca campaigns to raise awareness of knee injury risks in women. Rebecca shares her story with other people suffering from the same type of injury and strongly advocates patient self-education via the Internet.


Jean McCormick is media consultant. Previously she served as EVP of, a internet-based team sports aggregator, and as an executive consultant of SightPath, a networking company which was sold to Cisco Systems in 2000. Previously she was a visiting Scholar at the Center for Research on Women at Wellesley College. Prior to her appointment, she was the first female studio producer and coordinating producer at ESPN, the sports network, where she received seven Emmy Awards and two Cable Ace Awards. She holds an MBA from Harvard University.


David McLachlan is a professional director and corporate advisor. He serves as the corporate director at Alpha Industries Inc., Aronex Pharmaceuticals, Dyax Corp. and Hearx, Ltd.. Mr. McLachlan served as the Executive Vice President and Chief Financial Officer for Genzyme Corporation from 1989-1999. He currently is a part-time consultant to the Chairman and CEO of Genzyme. Mr. McLachlan is currently the Director and Treasurer of the Massachusetts Biotechnology Council. He holds a BA and a MBA from Harvard University.


Kenton Edelin has been an attorney for 12 years, representing professional athletes for the past seven. Mr. Edelin holds a BA and JD degree from the University of Virginia, where he played collegiate basketball, including in the 1984 NCAA Final Four. He also played for the Indiana Pacers NBA basketball team.


Lisa Lopez is Sr. Vice President, General Counsel and Clerk to the Board of Directors of The Haemonetics Corporation, a $300 million manufacturer of blood processing equipment. Her responsibilities at Haemonetics have included regulatory affairs, product submissions, regulatory compliance, investor relations and external affairs. Prior to Haemonetics, Lisa was an associate at Sullivan & Worcester concentrating in civil litigation with emphasis on employment law for corporate clients, including Haemonetics. Lisa currently serves on several boards and committees, including the New England Legal Foundation, MassMEDIC, AdvaMed’s Blood Sector Working Committee and the Center for Policy, Women & Families, and Employ+Ability. She holds a BA from Ohio State University as well as a JD from Yale Law School.


Dr. Stone is recognized internationally as an authority on cartilage growth, replacement and repair. He is a founder and chairman of the Stone Foundation for Sports Medicine and Arthritis Research, a leading center for treatment of athletes with joint injuries. A graduate of Harvard and the University of North Carolina School of Medicine, Dr. Stone has also been a physician for the U.S. Ski Team and the World Professional Ski Tour since 1988.


Jon J.P. Warner, M.D. is Associate Professor of the Harvard Combined Orthopaedic Surgery Department and Chief of the Harvard Shoulder Service. He has offices at Massachusetts General Hospital and Brigham and Women’s Hospital. He is the author of over 60 peer review publications, more than 150 book chapters, and 4 books. More than 30 regional, national and international awards have recognized his clinical and basic research. In 1994, he was selected as one of the two traveling fellows in the inaugural year of the fellowship to represent the American Shoulder and Elbow Surgeons to the European Society of Shoulder and Elbow Surgeons. He has been a Visiting Professor and Lecturer on 300 occasions at meetings and Universities throughout Europe, Asia, and the United States.

He is Board Certified in Orthopaedic Surgery and is a member of numerous specialty societies including the Orthopaedic Research Society, the American Shoulder and Elbow Surgeons, the American Orthopaedic Society for Sports Medicine, and the Arthroscopy Association of North America. His practice is principally devoted to the treatment of problems of the shoulder and elbow.


The team is led by Christopher ("Chris") Messina, a medical industry entrepreneur. His whole professional career has reflected his commitment to improving healthcare. He is a director of the Massachusetts Medical Device Industry Council and a corporator of the Harvard Medical School-affiliated Mt. Auburn Hospital. Previously he was CEO of General Orthopedics, Inc., a developer/manufacturer of medical devices to treat fractures and crippling deformities, and prior to that, a consultant to the US Congress, Office of Technology Assessment on international biotechnology . Chris began his career as a sales/marketing executive at Hewlett Packard. He was a Rotary International Fellow at the University of Sydney, where he studied the design of communities. Chris is a graduate (MBA) of the Harvard Business School where he co-founded Project Outreach, a non-profit program of community service. E-mail him your thoughts or comments at:


Henri A. Termeer is President, Chief Executive Officer, and Chairman of Genzyme Corporation, founded in 1981. With more than 3800 employees (2500 in Massachusetts), Genzyme has manufacturing facilities, research laboratories, and sales and marketing offices worldwide.

Mr. Termeer earned worldwide recognition for his contributions to the biotechnology industry and for his expertise in financing new initiatives. He serves on the board of directors of Abiomed, Inc.; Diacrin, Inc.; GelTex Pharmaceuticals; and Genzyme Transgenics Corp. He serves as a trustee for Hambrecht & Quist Health Care Investors and Hambrecht & Quist Life Sciences. He is on the board of associates of the Whitehead Institute, the Genetics Advisory Council of Harvard Medical School, and the Dean’s Advisory Council of MIT/Sloan. Additionally, Mr. Termeer serves on the board of directors of both the Biotechnology Industry Organization and PhRMA, the pharmaceutical trade organization.

Mr. Termeer actively participates in public service as a trustee for the Darden Graduate School of Business Administration, the Boston Museum of Science; he is also a member of the Massachusetts Governor's Council on Economic Growth and Technology, and the Massachusetts High Technology Council. Numerous organizations have honored him, among them the Anti-Defamation League's New England Region, which awarded him the Torch of Liberty Award. He is also the recipient of the International Institute of Boston’s Golden Door Award, the Genetic Disease Foundation’s Humanitarian Award, and is a Fellow of the American Academy of Arts and Sciences.


Dave Fleming is the Group Senior Vice President and a Corporate Officer of Genzyme Corporation. He is responsible for Genzyme Diagnostics, which manufactures more than 200 diagnostic products. He brings over 30 years of general management, sales and marketing responsibility in healthcare with emphasis on diagnostics, therapeutics, global business development and public policy. In the Greater Boston area, Dave Fleming co-founded MassMEDIC, HealthPoint and the New England Bone and Joint Institute. Nationally Dave is a member of the board of the Advanced Medical Technology Association (AdvaMed). Mr. Fleming holds a BA from the College of Wooster (Ohio) and an MBA from Pepperdine Unniversity.


Thomas W. Janes. Mr. Janes is the Managing Partner of Boston Capital Private Equity Partners. Boston Capital's primary focus is direct investments in: (i) minority buyouts and recapitalizations; (ii) minority growth equity transactions and (iii) mezzanine investments with a meaningful equity component. Boston Capital will invest in select industry sectors that offer above average growth. Sectors of interest include, but are not limited to, business services, media/telecommunications and healthcare services. Boston Capital will invest $5 - $15 million per transaction in profitable, growth-oriented private companies and will often seek to partner alongside value-added co-investors.
Prior to Boston Capital, Mr. Janes was a founding member and Managing Director of Triumph Capital, a Boston-based private equity firm with approximately $1.0 billion in capital under management. Previously, Mr. Janes served as Vice-President of investment banking and corporate finance at Drexel Burnham Lambert and First Boston Corp. Mr. Janes was previously an Associate with Lazard Freres and Bain & Co. Mr. Janes has served on the Board of Directors of numerous public and private companies during this period. Mr. Janes is a graduate of Harvard College (cum laude) and received an MBA from the Harvard Business School.

Home About Us Press Jobs Advertise With Us Contact Us
©1999- 2014 Body1 All rights reserved.
Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.